192 related articles for article (PubMed ID: 6456890)
1. Pharmacokinetics of cefoperazone: a review.
Craig WA; Gerber AU
Drugs; 1981; 22 Suppl 1():35-45. PubMed ID: 6456890
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
Greenfield RA; Gerber AU; Craig WA
Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
[TBL] [Abstract][Full Text] [Related]
3. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
Neu HC
Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
[TBL] [Abstract][Full Text] [Related]
5. Serum and urine concentrations of cefoperazone in severe chronic renal failure.
Bailey RR; Peddie B; Blake E
Drugs; 1981; 22 Suppl 1():46-51. PubMed ID: 6456891
[TBL] [Abstract][Full Text] [Related]
6. Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis.
Boscia JA; Korzeniowski OM; Snepar R; Kobasa WD; Levison ME; Kaye D
Antimicrob Agents Chemother; 1983 Mar; 23(3):385-9. PubMed ID: 6221691
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefoperazone in patients with neoplastic disease.
Maksymiuk AW; LeBlanc BM; Brown NS; Ho DH; Bodey GP
Antimicrob Agents Chemother; 1981 Jun; 19(6):1037-41. PubMed ID: 6455966
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
Muder RR; Agarwala S; Mirani A; Gayowski T; Venkataramanan R
J Clin Pharmacol; 2002 Jun; 42(6):644-50. PubMed ID: 12043952
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of a new cephalosporin, cefoperazone].
Allaz AF; Dayer P; Fabre J; Rudhardt M; Balant L
Schweiz Med Wochenschr; 1979 Dec; 109(50):1999-2005. PubMed ID: 538442
[TBL] [Abstract][Full Text] [Related]
11. Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan.
Saito A
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():255-62. PubMed ID: 6352628
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of the third generation cephalosporins.
Balant L; Dayer P; Auckenthaler R
Clin Pharmacokinet; 1985; 10(2):101-43. PubMed ID: 3888488
[TBL] [Abstract][Full Text] [Related]
14. Biliary excretion and pharmacokinetics of cefoperazone in humans.
Kemmerich B; Lode H; Borner K; Belmega D; Jendroschek T; Koeppe P; Goertz G
J Antimicrob Chemother; 1983 Jul; 12(1):27-37. PubMed ID: 6619045
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and metabolism of the cephalosporins].
Graninger W
Wien Klin Wochenschr Suppl; 1983; 142():11-5. PubMed ID: 6580781
[TBL] [Abstract][Full Text] [Related]
16. [Clinical investigation of the biliary excretion of cefoperazone in obstructive jaundice].
Matsumoto T; Moriwaki M; Iizuka Y
Jpn J Antibiot; 1986 Oct; 39(10):2795-802. PubMed ID: 3806961
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
Bolton WK; Scheld WM; Spyker DA; Sande MA
Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of five cephalosporins in healthy male volunteers.
Paradelis AG; Stathopoulos G; Trianthaphyllidis C; Logaras G
Arzneimittelforschung; 1977; 27(11):2167-70. PubMed ID: 580023
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of cefoperazone and cefamandole.
Srinivasan S; Francke EL; Neu HC
Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
